Efflux <i>MexAB</i>-Mediated Resistance in <i>P. aeruginosa</i> Isolated from Patients with Healthcare Associated Infections

Today, one of the most important challenges for physicians is the adequate treatment of infections due to multidrug resistant organism (MDR). <i>Pseudomonas aeruginosa</i> is considered an opportunistic organism causing different types of healthcare associated infections (HAIs). We aimed...

Full description

Bibliographic Details
Main Authors: Rania M. Kishk, Mohamed O. Abdalla, Abdullah A. Hashish, Nader A. Nemr, Nihal El Nahhas, Saad Alkahtani, Mohamed M. Abdel-Daim, Safaa M. Kishk
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/9/6/471
_version_ 1797565289146089472
author Rania M. Kishk
Mohamed O. Abdalla
Abdullah A. Hashish
Nader A. Nemr
Nihal El Nahhas
Saad Alkahtani
Mohamed M. Abdel-Daim
Safaa M. Kishk
author_facet Rania M. Kishk
Mohamed O. Abdalla
Abdullah A. Hashish
Nader A. Nemr
Nihal El Nahhas
Saad Alkahtani
Mohamed M. Abdel-Daim
Safaa M. Kishk
author_sort Rania M. Kishk
collection DOAJ
description Today, one of the most important challenges for physicians is the adequate treatment of infections due to multidrug resistant organism (MDR). <i>Pseudomonas aeruginosa</i> is considered an opportunistic organism causing different types of healthcare associated infections (HAIs). We aimed to investigate the MDR and pandrug resistance (PDR) rate in <i>P. aeruginosa</i> in our region and detect efflux-pump <i>mexAB</i> genes and the proposed binding interactions of five different categories of antimicrobial agents with the <i>mexB</i> pump. A total of 180 non-duplicated <i>P. aeruginosa strains</i> were isolated from patients with HAIs in the Suez Canal University Hospital. Phenotypically, minimum inhibitory concentration (MIC) was done for all MDR and PDR strains before and after addition of efflux pump inhibitor carbonyl cyanide m-chlorophenyl hydrazone (CCCP). Molecular detection of <i>mexA</i> and <i>mexB</i> genes was done by using polymerase chain reaction (PCR). Most of the isolated strains (126 strains) were MDR (70%); only 10 samples (5.5%) were PDR. <i>MexA</i> and <i>mexB</i> genes were detected in 88.2% (120 strains) and 70.5% (96 strains) of stains, respectively. All PDR strains (10 stains) carried both <i>mexA</i> and <i>mexB</i> genes. Efflux <i>mexAB</i> genes were detected in all MDR and PDR strains (136 strains). Molecular modeling studies were performed to investigate the modes of intermolecular binding interactions between the antimicrobial agents and <i>mexB</i> key amino acids that resulted in MDR and PDR. The current study reported high prevalence of MDR and PDR <i>P. aeruginosa</i> in patients with HAIs in the Suez Canal University Hospitals.
first_indexed 2024-03-10T19:10:00Z
format Article
id doaj.art-4454d9317a5342a6b1e126bdcbdaa740
institution Directory Open Access Journal
issn 2076-0817
language English
last_indexed 2024-03-10T19:10:00Z
publishDate 2020-06-01
publisher MDPI AG
record_format Article
series Pathogens
spelling doaj.art-4454d9317a5342a6b1e126bdcbdaa7402023-11-20T03:52:52ZengMDPI AGPathogens2076-08172020-06-019647110.3390/pathogens9060471Efflux <i>MexAB</i>-Mediated Resistance in <i>P. aeruginosa</i> Isolated from Patients with Healthcare Associated InfectionsRania M. Kishk0Mohamed O. Abdalla1Abdullah A. Hashish2Nader A. Nemr3Nihal El Nahhas4Saad Alkahtani5Mohamed M. Abdel-Daim6Safaa M. Kishk7Department of Microbiology and Immunology, Faculty of Medicine, Suez Canal University, Ismailia 41522, EgyptDepartment of Clinical Pathology, Faculty of Medicine, Suez Canal University, Ismailia 41522, EgyptDepartment of Clinical Pathology, Faculty of Medicine, Suez Canal University, Ismailia 41522, EgyptEndemic and Infectious Diseases, Faculty of Medicine, Suez Canal University, Ismailia 41522, EgyptDepartment of Botany, Faculty of Science, Alexandria University, Moharram baik, Alexandria 21515, EgyptDepartment of Zoology, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi ArabiaDepartment of Zoology, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi ArabiaDepartment of Medicinal Chemistry, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, EgyptToday, one of the most important challenges for physicians is the adequate treatment of infections due to multidrug resistant organism (MDR). <i>Pseudomonas aeruginosa</i> is considered an opportunistic organism causing different types of healthcare associated infections (HAIs). We aimed to investigate the MDR and pandrug resistance (PDR) rate in <i>P. aeruginosa</i> in our region and detect efflux-pump <i>mexAB</i> genes and the proposed binding interactions of five different categories of antimicrobial agents with the <i>mexB</i> pump. A total of 180 non-duplicated <i>P. aeruginosa strains</i> were isolated from patients with HAIs in the Suez Canal University Hospital. Phenotypically, minimum inhibitory concentration (MIC) was done for all MDR and PDR strains before and after addition of efflux pump inhibitor carbonyl cyanide m-chlorophenyl hydrazone (CCCP). Molecular detection of <i>mexA</i> and <i>mexB</i> genes was done by using polymerase chain reaction (PCR). Most of the isolated strains (126 strains) were MDR (70%); only 10 samples (5.5%) were PDR. <i>MexA</i> and <i>mexB</i> genes were detected in 88.2% (120 strains) and 70.5% (96 strains) of stains, respectively. All PDR strains (10 stains) carried both <i>mexA</i> and <i>mexB</i> genes. Efflux <i>mexAB</i> genes were detected in all MDR and PDR strains (136 strains). Molecular modeling studies were performed to investigate the modes of intermolecular binding interactions between the antimicrobial agents and <i>mexB</i> key amino acids that resulted in MDR and PDR. The current study reported high prevalence of MDR and PDR <i>P. aeruginosa</i> in patients with HAIs in the Suez Canal University Hospitals.https://www.mdpi.com/2076-0817/9/6/471efflux pumpMexAB<i>Pseudomonas aeruginosa</i>HAIsEgyptmolecular modeling
spellingShingle Rania M. Kishk
Mohamed O. Abdalla
Abdullah A. Hashish
Nader A. Nemr
Nihal El Nahhas
Saad Alkahtani
Mohamed M. Abdel-Daim
Safaa M. Kishk
Efflux <i>MexAB</i>-Mediated Resistance in <i>P. aeruginosa</i> Isolated from Patients with Healthcare Associated Infections
Pathogens
efflux pump
MexAB
<i>Pseudomonas aeruginosa</i>
HAIs
Egypt
molecular modeling
title Efflux <i>MexAB</i>-Mediated Resistance in <i>P. aeruginosa</i> Isolated from Patients with Healthcare Associated Infections
title_full Efflux <i>MexAB</i>-Mediated Resistance in <i>P. aeruginosa</i> Isolated from Patients with Healthcare Associated Infections
title_fullStr Efflux <i>MexAB</i>-Mediated Resistance in <i>P. aeruginosa</i> Isolated from Patients with Healthcare Associated Infections
title_full_unstemmed Efflux <i>MexAB</i>-Mediated Resistance in <i>P. aeruginosa</i> Isolated from Patients with Healthcare Associated Infections
title_short Efflux <i>MexAB</i>-Mediated Resistance in <i>P. aeruginosa</i> Isolated from Patients with Healthcare Associated Infections
title_sort efflux i mexab i mediated resistance in i p aeruginosa i isolated from patients with healthcare associated infections
topic efflux pump
MexAB
<i>Pseudomonas aeruginosa</i>
HAIs
Egypt
molecular modeling
url https://www.mdpi.com/2076-0817/9/6/471
work_keys_str_mv AT raniamkishk effluximexabimediatedresistanceinipaeruginosaiisolatedfrompatientswithhealthcareassociatedinfections
AT mohamedoabdalla effluximexabimediatedresistanceinipaeruginosaiisolatedfrompatientswithhealthcareassociatedinfections
AT abdullahahashish effluximexabimediatedresistanceinipaeruginosaiisolatedfrompatientswithhealthcareassociatedinfections
AT naderanemr effluximexabimediatedresistanceinipaeruginosaiisolatedfrompatientswithhealthcareassociatedinfections
AT nihalelnahhas effluximexabimediatedresistanceinipaeruginosaiisolatedfrompatientswithhealthcareassociatedinfections
AT saadalkahtani effluximexabimediatedresistanceinipaeruginosaiisolatedfrompatientswithhealthcareassociatedinfections
AT mohamedmabdeldaim effluximexabimediatedresistanceinipaeruginosaiisolatedfrompatientswithhealthcareassociatedinfections
AT safaamkishk effluximexabimediatedresistanceinipaeruginosaiisolatedfrompatientswithhealthcareassociatedinfections